Primary: ventilation >24h Secondary: stroke, heart attack, COPD, pneumonia, colorectal resection Not Applicable
Conditions
Interventions
The IMPRESS study is a two-armed cluster-randomized controlled intervention trial embedded in a prospective hospital-cohort study. 385 IQM-member-hospitals from Germany are invited to participate. 60
Sponsors
German Research Centre for Air and Space Travel (DLR)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Hospital: 1. Member of the Association Initiative Quality in Medicine 2. Located in Germany 3. Treating 10 patients in 2016 who were ventilated > 24h 4. Consented into the study in the written form
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age- and sex-adjusted mean inpatient mortality rate of hospitals in the intervention or control group within one year before (baseline) and one year follow-up after the peer-review procedure (post-intervention). The primary outcome is measured for patients who receive ventilation >24h | — |
Secondary
| Measure | Time frame |
|---|---|
| Age- and sex-adjusted mean inpatient mortality rate of every participating hospital regardless of observation, intervention or control group in 2016, 2017 and 2018. The secondary outcome is measured for patients who receive ventilation >24h and colorectal resection or patients with myocardial infarction, stroke, COPD and pneumonia, respectively. For all analyses the unit of analysis is the hospital, not the individual patient. | — |
Countries
Germany
Contacts
Public ContactFelix Walther
Outcome results
None listed